Latest filing published 26 Jun 2026 for Praxis Precision Medicines, Inc.. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jill DeSimone appears in our data through filings on Praxis Precision Medicines, Inc. shares, published by SEC (Form 4). Between 5 October 2023 and 24 June 2026, the trades on record add up to 15 filings.
The open-market side counts 1 purchase for €24k alongside 12 sales. The amount is not disclosed for 12 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. So far in 2026, the count stands at no purchases and 12 sales.
Most recently, on 26 June 2026, the filings show an open-market sale in Praxis Precision Medicines, Inc. The clock since the last published purchase (10 October 2023) now reads 1,104 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations